BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang YW, Wang XH, Wang HX, Yu RH. Successful treatment of patients with refractory idiopathic membranous nephropathy with low-dose Rituximab: A single-center experience. World J Clin Cases 2023; 11(3): 566-575 [PMID: 36793628 DOI: 10.12998/wjcc.v11.i3.566]
URL: https://www.wjgnet.com/2307-8960/full/v11/i3/566.htm
Number Citing Articles
1
L.D. Denova, I.V. Krasiuk. A clinical case of primary membranous glomerulonephritis with nephrotic syndrome and resistance to standard treatmentKIDNEYS 2023; 12(4): 211 doi: 10.22141/2307-1257.12.4.2023.431
2
Yang Yang, Kaiqi Cheng, Gaosi Xu. Novel approaches to primary membranous nephropathy: Beyond the KDIGO guidelinesEuropean Journal of Pharmacology 2024; 982: 176928 doi: 10.1016/j.ejphar.2024.176928